World Investment Advisors bought a new stake in The Clorox Company (NYSE:CLX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,998 shares of the company's stock, valued at approximately $324,000.
A number of other large investors also recently added to or reduced their stakes in CLX. Vanguard Group Inc. grew its holdings in shares of Clorox by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company's stock valued at $2,518,517,000 after purchasing an additional 124,428 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Clorox by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company's stock worth $501,925,000 after acquiring an additional 69,969 shares in the last quarter. Norges Bank purchased a new stake in shares of Clorox during the fourth quarter worth $259,041,000. Amundi raised its stake in shares of Clorox by 42.6% in the fourth quarter. Amundi now owns 1,032,283 shares of the company's stock valued at $165,816,000 after acquiring an additional 308,234 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Clorox by 3.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 748,120 shares of the company's stock valued at $121,502,000 after purchasing an additional 24,214 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Clorox Stock Performance
Shares of NYSE CLX traded down $0.79 during trading hours on Monday, reaching $140.65. The stock had a trading volume of 261,684 shares, compared to its average volume of 1,294,194. The firm has a 50-day moving average of $147.39 and a 200-day moving average of $157.21. The firm has a market cap of $17.33 billion, a price-to-earnings ratio of 38.43, a PEG ratio of 2.62 and a beta of 0.61. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the company earned $2.16 earnings per share. Equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.47%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.
Analyst Ratings Changes
Several equities analysts have recently issued reports on CLX shares. JPMorgan Chase & Co. decreased their price objective on Clorox from $173.00 to $151.00 and set a "neutral" rating for the company in a research note on Friday. Barclays decreased their price target on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a research note on Friday. Wells Fargo & Company dropped their price objective on shares of Clorox from $161.00 to $155.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 2nd. Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $156.75.
Read Our Latest Analysis on CLX
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
